Recent Updates
Recently added Catalysts
ABBV Positive Sentiment

AbbVie to Present at the Leerink Partners Global Healthcare Conference AbbVie (NYSE: ABBV) will participate at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025. Management will participate in...

Tuesday, March 4, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: AbbVie (NYSE: ABBV) is set to present at the Leerink Partners Global Healthcare Conference on March 11, 2025, with a fireside chat scheduled for 7:40 a.m. Central time. The event will be accessible through a live audio webcast on AbbVie's Investor Relations website, followed by an archived version later that day. AbbVie aims to showcase its mission of delivering innovative medicines across key therapeutic areas, including immunology and oncology.
Price reaction · baseline $211.48 (2025-03-03 close) · hit after-hours · clean, no other ABBV news in the window
day 0 close · peak
-1.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • AbbVie will highlight its innovations in addressing serious health issues.
  • Participation in a prominent healthcare conference shows a proactive approach to investor relations.
  • Management's engagement via a fireside chat suggests transparency and accessibility.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+33%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
paricalcitol
Phase 3 · Secondary Hyperparathyroidism

Full Press Release Details

NORTH CHICAGO, Ill. , March 4, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV ) will participate at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025 . Management will participate in a fireside chat at 7:40 a.m. Central time .
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com . An archived edition of the session will be available later that day.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X (formerly Twitter) , and YouTube.
Media: Investors:
Gabby Tarbert Liz Shea
(224) 244-0111 (847) 935-2211
[email protected] [email protected]

Frequently Asked Questions

When is AbbVie's participation in the Leerink Partners Conference?

AbbVie will participate on March 11, 2025, at 7:40 a.m. Central time.

Where can I access the live webcast of AbbVie's presentation?

The live audio webcast will be available on AbbVie's Investor Relations website.

What is AbbVie's mission?

AbbVie's mission is to discover and deliver innovative medicines for serious health issues.

Which therapeutic areas does AbbVie focus on?

AbbVie focuses on immunology, oncology, neuroscience, eye care, and aesthetics.

How can I follow AbbVie on social media?

You can follow AbbVie on LinkedIn, Facebook, Instagram, X, and YouTube.

ShareAdd on Google
Tags: ABBV Viatris Investor Conferences Healthcare AbbVie Leerink Partners healthcare conference innovative medicines immunology
Last updated: Mar 4, 2025

Biotech snapshot

Cash runway
$6569M liquidity · $0M/mo burn
Low dilution risk
Lead asset
paricalcitolPhase 3
Secondary Hyperparathyroidism →

Catalyst track record

+33%
best trade around ABBV's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for ABBV.

See every catalyst's timing & PoA →